• Moderna EPS for the quarter ending March 31, 2025 was $-2.52, a 17.92% decline year-over-year.
• Moderna 2024 annual EPS was $-9.28, a 24.74% decline from 2023.
• Moderna 2023 annual EPS was $-12.33, a 161.28% decline from 2022.
• Moderna 2022 annual EPS was $20.12, a 28.88% decline from 2021.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.